Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Ruchi Patel

4PUBLICATIONS

64CO-AUTHORS

Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunology

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|Jan 06, 2026

Harnessing the CD2 axis to broaden and enhance the efficacy of CAR T-cell therapies.

Alberto Carturan, Mathew G Angelos, Puneeth Guruprasad

|Jul 19, 2024

CD5 deletion enhances the antitumor activity of adoptive T cell therapies.

Ruchi P Patel, Guido Ghilardi, Yunlin Zhang

|Jun 03, 2024

The BTLA-HVEM axis restricts CAR T cell efficacy in cancer.

Puneeth Guruprasad, Alberto Carturan, Yunlin Zhang

|Jul 29, 2022

Modulation of BCL-2 in Both T Cells and Tumor Cells to Enhance Chimeric Antigen Receptor T-cell Immunotherapy against Cancer.

Yong Gu Lee, Puneeth Guruprasad, Guido Ghilardi

Pageof 1

Frequent Collaborators

4 joint publications

Marco Ruella

3 joint publications

Stephen J Schuster

3 joint publications

Luca Paruzzo

3 joint publications

Yunlin Zhang

3 joint publications

Patrizia Porazzi

3 joint publications

Raymone Pajarillo

2 joint publications

Dongfang Liu

2 joint publications

Guido Ghilardi

2 joint publications

Yong Gu Lee

2 joint publications

Mathew G Angelos

Frequent Collaborators

4 joint publications

Marco Ruella

3 joint publications

Stephen J Schuster

3 joint publications

Luca Paruzzo

3 joint publications

Yunlin Zhang

Top Related Videos

Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy

Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy

Published on : Dec 17, 2019

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on : Feb 16, 2015

Generation and Functional Verification of Hypoxia-Sensitive Chimeric Antigen Receptor-T Cells

Generation and Functional Verification of Hypoxia-Sensitive Chimeric Antigen Receptor-T Cells

Published on : Jun 14, 2024

See more related videos

Top Related Videos

Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy

Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy

Published on : Dec 17, 2019

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on : Feb 16, 2015

Generation and Functional Verification of Hypoxia-Sensitive Chimeric Antigen Receptor-T Cells

Generation and Functional Verification of Hypoxia-Sensitive Chimeric Antigen Receptor-T Cells

Published on : Jun 14, 2024

See more related videos